| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Co. &Man. Dir. Of China | Co &Man. Dir. Of China +1 more
1 company
Neidig Brent is a Chief Commercial Officer at USNA. Recent filings cover 0 purchases and 14 sales.
Our model assigns Neidig Brent a strong insider score of 74/100, based on 7 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +31.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2020 | USNA Usana Health Sciences Inc | Chief Officer &MD Of China | Sell | 260 | $83.76 | $21,776.30 | -100% | |
| Apr 27, 2020 | USNA Usana Health Sciences Inc | Chief Officer &MD Of China | Sale+OE | 1,831 | $84.75 | $155,173.59 | -100% | |
| Feb 6, 2020 | USNA Usana Health Sciences Inc | Chief Officer &MD Of China | Sale+OE | 2,203 | $79.97 | $176,167.00 | -37.6% |